Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Radiosurgery × 30 days × Clear all

Sponsor

Conditions

Brain Neoplasms 11 Lung Neoplasms 10 Prostatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 5 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Melanoma 3 Liver Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 2 Uveal Melanoma 1 Thoracic Neoplasms 1 Spinal Cord Neoplasms 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostate CA 1 Prostate Adenocarcinoma 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1 Mouth Neoplasms 1 Meningioma 1 Lung Diseases 1

Interventions

pembrolizumab 2 fludarabine 2 blinatumomab 2 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 relugolix 1 nilotinib 1 isatuximab 1 inavolisib 1 giredestrant 1 fludarabine phosphate 1 enzalutamide 1 abemaciclib 1 Transplantation 1 Monatide (IMS 3015) 1 Melphalan 1 Lenalidomide 1 Immunotherapy 1 Imatinib Mesylate 1 HMPL-013 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Biological Assay 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡